Articles related to CONTRACEPTION/BIRTH CONTROL

A Maryland family was awarded almost $34 million after an unnecessary emergency C-section led to brain damage in their infant. This case serves as a stark reminder of the potential consequences of medical decisions and the importance of effective communication within healthcare teams.

The recent study underscores the readiness of pharmacists to dispense mifepristone following the FDA’s rule change. With basic training, nearly all participants expressed confidence in their ability to dispense this medication, highlighting your adaptability and resourcefulness.

ACIP’s endorsement of Abrysvo offers a new preventive measure against RSV in infants, urging healthcare providers to discuss this option with expectant parents.

New research identifies the placenta as a significant factor in schizophrenia risk, revealing more than 100 genes that impact the disorder and suggesting new avenues for prevention and treatment.

This landmark study provides crucial insights into the safety of anti-seizure medications during pregnancy, offering both reassurance to prospective mothers and important guidelines for healthcare providers.

This case study reveals the ethical and medical dilemmas that can arise from non-disclosure of mental health conditions in postpartum care. Learn how this lack of transparency impacted both the patient and her newborn, and what it means for medical ethics and patient safety.